The agonising negative trend in monitoring of clinical trials (Q33809318)

29 July 2017

1 reference

title

The agonising negative trend in monitoring of clinical trials (English)

1 reference

29 July 2017

D L DeMets

1

1 reference

29 July 2017

S J Pocock

series ordinal

2

1 reference

29 July 2017

D G Julian

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

354

1 reference

29 July 2017

issue

9194

1 reference

29 July 2017

page(s)

1983-1988

1 reference

Organization, review, and administration of cooperative studies (greenberg report): A report from the heart special project committee to the National Advisory heart council, May 1967

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Monitoring of clinical trials: issues and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

When to stop a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Interim analysis: the alpha spending function approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

The B-Value: A Tool for Monitoring Data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

The what, why and how of Bayesian clinical trials monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903464-9

7 January 2021

10.1016/S0140-6736(99)03464-9

Identifiers

DOI

1 reference

29 July 2017

1 reference